21 July 2021 - Insurers have been advised that they shouldn’t be charging for Truvada and Descovy as HIV prevention and that associated clinic visits and labs must also be free.
In a move that is expected to prove transformative to the national HIV-prevention effort, the federal government has announced that almost all health insurers must cover the HIV prevention pill, known as PrEP, or pre-exposure prophylaxis, with no cost sharing — including for the drug itself and, crucially, for clinic visits and lab tests.